Inversions of the factor VIII gene in Japanese patients with severe hemophilia A

被引:11
|
作者
Fukuda, K [1 ]
Naka, H [1 ]
Morichika, S [1 ]
Shibata, M [1 ]
Tanaka, I [1 ]
Shima, M [1 ]
Yoshioka, A [1 ]
机构
[1] Nara Med Univ, Dept Pediat, Nara 6348522, Japan
关键词
hemophilia A; inhibitor; inversion; carrier detection;
D O I
10.1532/IJH97.03138
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hemophilia A is genetically very heterogeneous because disease-causing mutations involving deletions, point mutations, insertions, and inversions are scattered throughout the factor VIII gene. Of these mutations, inversions, which are intrachromosomal recombinations between int22h-1 (intron 22 homologous region 1) and I of 2 other extragenic copies located 500 kilobases upstream, are the more frequently found defects, especially in patients with severe hemophilia A. Reportedly, approximately half of all severe hemophilia A patients have inversions in intron 22. A group of unrelated patients from the middle of Japan with severe hemophilia A were screened by Southern blot analysis for gene inversions. Forty-two of 100 severely affected patients presented factor VIII gene rearrangements. Of these patients, 36 exhibited the distal type of inversion, and 6 exhibited the proximal type. No other variant type of recombination was observed. In this study, neither the prevalence of inhibitor development against factor VIII nor the frequency of sporadic cases in the group presenting gene inversions was significantly different from that in the group without chromosomal inversions. Southern blot analysis successfully detected a carrier in a hemophilia family for which no patient was available. Genetic counseling of patients with severe hemophilia A and their families will be considerably improved, because the inversions occur in 42% of the Japanese patients with severe hemophilia. (C) 2004 The Japanese Society of Hematology.
引用
收藏
页码:303 / 306
页数:4
相关论文
共 50 条
  • [41] Factor VIII/factor IX prophylaxis for severe hemophilia
    Carcao, Manuel
    Srivastava, Alok
    SEMINARS IN HEMATOLOGY, 2016, 53 (01) : 3 - 9
  • [42] Factor VIII Products and Inhibitors in Severe Hemophilia A
    Iorio, Alfonso
    Skinner, Mark W.
    Makris, Mike
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (15): : 1456 - 1456
  • [43] Frequencies of intron 1 and 22 inversions of factor VIII gene: A first report in Afghan patients with severe haemophilia A
    Mousavi, S. H.
    Mesbah-Namin, S. A.
    Rezaie, N.
    Zeinali, S.
    HAEMOPHILIA, 2018, 24 (03) : E157 - E160
  • [44] Factor VIII Intron 22 Inversion in Severe Hemophilia A Patients in Palestine
    Abu Arra, Caesar Mahmoud
    Samarah, Fekri
    Abu Hasan, Nael Sudqi
    SCIENTIFICA, 2020, 2020
  • [45] Evaluation of factor VIII prophylaxis of plasmatic origin in patients with severe hemophilia A
    Sambolino, Fabiana
    Medina, Vania
    Bentos, Jimena
    Torres, Rommel
    Berro, Maximiliano
    Canessa, Cecilia
    Rodriguez, Ismael
    Turcatti, Paola
    Insagaray, Juan
    REVISTA MEDICA DEL URUGUAY, 2022, 38 (04):
  • [46] FACTOR-VIII REARRANGEMENTS IN PATIENTS WITH SEVERE HEMOPHILIA-A IN GREECE
    KOUMBARELIS, E
    GIALERAKI, A
    BOWEN, DJ
    MANDALAKI, T
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1218 - 1218
  • [47] Non-viral gene transfer of blood coagulation factor VIII in patients with severe hemophilia A.
    Roth, DA
    Tawa, NE
    O'Brien, J
    Levine, JD
    Furie, B
    Furie, BC
    Proper, J
    Roman, VA
    Sabine, ZM
    Lamsa, JC
    Gunter, KC
    Phillips, CW
    Savioli, NA
    Treco, DA
    Selden, RF
    BLOOD, 2000, 96 (11) : 590A - +
  • [48] Prevalence of the intron 22 inversion of the factor VIII gene and inhibitor development in Polish patients with severe hemophilia A
    Sawecka, J
    Skulimowska, J
    Windyga, J
    Lopaciuk, S
    Koscielak, J
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2005, 53 (04) : 352 - 356
  • [49] Type of FVIII product and inhibitor risk in patients with severe hemophilia A and null mutations in the factor VIII gene
    Santagostino, E.
    Mancuso, M. E.
    Rocino, A.
    Tagliaferri, A.
    Margaglione, M.
    Mannucci, P.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 55 - 55
  • [50] Influence of the type of factor VIII concentrate on the incidence of factor VIII inhibitors in previously untreated patients with severe hemophilia A
    Goudemand, J
    Rothschild, C
    Demiguel, V
    Vinciguerrat, C
    Lambert, T
    Chambost, H
    Borel-Derlon, A
    Claeyssens, S
    Laurian, Y
    Calvez, T
    BLOOD, 2006, 107 (01) : 46 - 51